UCP2 and Obesity: Several population studies now show that a common functional polymorphism in the UCP2 promoter (-866G/A, the same polymorphism found to be associated with resistance to obesity in Caucasians) enhances UCP2 transcriptional activity [43] and increases the risk of developing type-2 diabetes [44].